In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent

Citations Over TimeTop 1% of 2010 papers

Abstract

A novel nanoparticle-based dual-modality positron emission tomograph/magnetic resonance imaging (PET/MRI) contrast agent was developed. The probe consisted of a superparamagnetic iron oxide (SPIO) core coated with PEGylated phospholipids. The chelator 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid (DOTA) was conjugated to PEG termini to allow labeling with positron-emitting (64)Cu. Radiolabeling with (64)Cu at high yield and high purity was readily achieved. The (64)Cu-SPIO probes produced strong MR and PET signals and were stable in mouse serum for 24 h at 37 degrees C. Biodistribution and in vivo PET/CT imaging studies of the probes showed a circulation half-life of 143 min and high initial blood retention with moderate liver uptake, making them an attractive contrast agent for disease studies.

Related Papers

• → Molecular probes for the in vivo imaging of cancer(2009)73 cited
• → Bioresponsive probes for molecular imaging: concepts and in vivo applications(2015)31 cited
• → In Vivo Molecular Imaging for Biomedical Analysis and Therapies(2018)16 cited
• → Molecular imaging using PET for breast cancer(2015)33 cited
• → Gadolinium Cryptelates as MR Contrast Agents(1987)21 cited